Prometheus Recalls Mercaptopurine Tablets for Failed Dissolution Specifications
Prometheus Laboratories is recalling Mercaptopurine Tablets 50mg because the product failed dissolution specifications during stability testing.
- Product
- Mercaptopurine Tablets, USP 50mg, a) 60-count bottle (NDC 49884-922-02), b) 250-count bottle (NDC 49884-922-04), RX only, Manufactured by Stason Pharmaceuticals, Inc., 11 Morgan, Irvine, CA 92618 for Prometheus Laboratories, Inc., 9410 Carroll Park Drive, San Diego, CA 92121
- Category
- Drug
- Distribution
- Distributed nationwide